EVP R&D, Chief Medical Officer
Mon, Dec 9, 2024
Dec 9
61,151 shares @ $32.07
Decreased holdings by -56.20%
6th largest trade (out of 157)
Planned (10b5-1)Large Trade
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 18% above 200-day moving average